Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Rakesh K. Jain · Nature Medicine · 2001
Cited by 2,182 works. doi:10.1038/nm0901-987
References
- Angiogenesis in cancer and other diseases
- Genes Expressed in Human Tumor Endothelium
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
- Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
- Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
- Barriers to Drug Delivery in Solid Tumors
- Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
- Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
- The next frontier of molecular medicine: Delivery of therapeutics